Psychiatric Fraud Rampant
Monday, October 6th, 2008As this recent NY Times article on Psychiatric Fraud brings to light, there is a lot of money flowing from drug companies to the psychiatrists who review their drugs. As reported in this story, Dr. Charles B. Nemeroff of Emory University, who has been a “leading light” in psychiatry with over 850 articles published, and who held the position of editor in chief at Neuropsychopharmacology, a “prestigious” journal in which psych drugs are discussed and reviewed. Dr. Nemeroff has received over $170,000 in just one year from GlaxoSmithKline. So basically he has been hip-deep in the pockets …






